Monopar Therapeutics (MNPR) — SC 13D/A Filings
All SC 13D/A filings from Monopar Therapeutics. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Tactic Pharma LLC Amends Monopar Therapeutics Stake
— Dec 17, 2024 Risk: medium
Tactic Pharma LLC, through an amendment filed on December 17, 2024, has updated its Schedule 13D regarding Monopar Therapeutics Inc. The filing indicates a chan
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX